In a patient with chronic bradycardia (30–50 bpm) who has received a pacemaker, is anxiety a normal response when the heart rate increases to a normal resting rate or to the 80s bpm during activity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anxiety After Pacemaker Implantation in Chronic Bradycardia Patients

Yes, anxiety is a normal and common response when patients with chronic bradycardia (30-50 bpm) experience higher heart rates (normal resting or 80s during activity) after pacemaker placement, affecting approximately 26-51% of pacemaker recipients.

Understanding the Psychological Response

Prevalence and Recognition

Anxiety following pacemaker implantation is well-documented in the literature. Recent data shows that 25.9% of pacemaker patients experience clinically significant anxiety, with this being a recognized complication of device therapy 1. The anxiety often stems from the patient's unfamiliarity with what "normal" heart rates feel like after years of chronic bradycardia.

Why This Happens

Patients who have lived with heart rates of 30-50 bpm for extended periods have physiologically and psychologically adapted to this state. When the pacemaker suddenly normalizes their heart rate to 60-80 bpm at rest or 80s-100s with activity, several factors contribute to anxiety:

  • Sensory unfamiliarity: The sensation of a "faster" heart rate feels abnormal despite being physiologically appropriate
  • Heightened awareness: Increased cardiac output and improved perfusion can make patients more aware of their heartbeat
  • Fear of malfunction: Patients may worry the device is malfunctioning or pacing inappropriately
  • Loss of control: Dependence on an electronic device can trigger anxiety about device failure

Clinical Context from Guidelines

The ACC/AHA/HRS guidelines emphasize that pacemaker implantation is indicated specifically for symptomatic bradycardia and chronotropic incompetence 2. The goal is to achieve appropriate heart rate responses to activity, which means heart rates in the 80s during activity are not only normal but therapeutically desired 3.

Modern pacemakers are often programmed with rate-responsive features that allow heart rate to increase appropriately with physical activity, typically targeting 80% of maximum predicted heart rate (220 minus age) during peak exercise 3, 2. This means a heart rate in the 80s during activity represents proper pacemaker function, not a problem.

Clinical Management Approach

Immediate Assessment

When a patient reports anxiety about their heart rate post-pacemaker:

  1. Verify appropriate pacemaker function: Interrogate the device to confirm it's operating within programmed parameters
  2. Correlate symptoms with heart rate: Document whether anxiety occurs specifically when heart rate increases
  3. Rule out inappropriate programming: Ensure rate-responsive settings aren't causing excessive tachycardia

Patient Education Strategy

Education and psychological support before, during, and after pacemaker insertion are highly desirable 3. Specifically address:

  • Normalize the experience: Explain that feeling the heart beat "faster" is expected and therapeutic
  • Provide concrete numbers: Show them their heart rate data demonstrating appropriate responses
  • Explain chronotropic competence: Describe how healthy hearts naturally increase to 80-100+ bpm with activity
  • Reassure about safety: Modern pacemakers have upper rate limits preventing dangerous tachycardia

Psychological Intervention Thresholds

Research demonstrates that anxiety and depression are potentially harmful outcomes requiring attention 4, 5. Consider formal psychological evaluation if:

  • Anxiety persists beyond 3-6 months post-implantation
  • Symptoms interfere with daily activities or quality of life
  • Patient develops avoidance behaviors (limiting activity to prevent heart rate increases)
  • Clinical anxiety scores are elevated on standardized testing (HADS scale)

Studies show that staged changes in anxiety disorders occur after primary pacemaker implantation, with improvement typically seen in uncomplicated cases 5. However, patients with mental disorders diagnosed early after implantation (within 3.2 years) show worse long-term outcomes 6.

Common Pitfalls to Avoid

Don't Dismiss the Concern

While the anxiety may be "normal" in terms of prevalence, it requires acknowledgment and management. Approximately 51.5% of pacemaker patients develop clinical symptoms of anxiety 5, making this a majority experience rather than an outlier.

Don't Assume Malfunction

The reflexive response to patient anxiety shouldn't be repeated device interrogations if the pacemaker is functioning appropriately. This can reinforce the patient's fear that something is wrong.

Don't Overlook Age and Gender Factors

Male pacemaker patients, particularly those under 50 years, show significantly higher risk of mental health issues (HR 1.42 for age <50) 6. Younger patients may require more intensive psychological support.

Practical Reassurance Points

For patients experiencing this anxiety, emphasize:

  • Heart rates of 60-100 bpm at rest are normal for the general population
  • Heart rates of 80-120 bpm during moderate activity are physiologically appropriate
  • The pacemaker has upper rate limits (typically 110-130 bpm) preventing dangerous tachycardia 7
  • Improved cardiac output from appropriate heart rates will enhance their exercise capacity and quality of life
  • The sensation will become more familiar over weeks to months

Timeline for Adaptation

Most patients regain emotional stability within several weeks post-implantation 8, though some require longer adaptation periods. Continuous psychological care and patient education can accelerate this process 9.

When to Refer

Consider cardiology or electrophysiology re-evaluation if:

  • Pacemaker interrogation reveals inappropriate rate-responsive programming
  • Patient has documented heart rates exceeding programmed upper limits
  • Symptoms suggest pacemaker syndrome (despite appropriate settings)

Consider mental health referral if:

  • Anxiety persists beyond 6 months with appropriate device function
  • Patient develops depression (18.9% prevalence in pacemaker patients) 1
  • Quality of life remains significantly impaired despite reassurance

The key message: anxiety about normal heart rates post-pacemaker is common, expected, and manageable with education and time, but requires clinical attention rather than dismissal.

References

Research

Evaluatıon of Depressıon and Anxıety Status in Patıents After Cardıac Devıce Implantatıon.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2025

Research

The effect of right ventricle septal pacing versus apical pacing in dual-chamber pacemakers on patients' anxiety and depression: a one-year follow-up study.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology, 2024

Related Questions

What is the appropriate treatment for an adult patient with incidentally discovered asymptomatic bradycardia (heart rate consistently below 50 beats per minute) and no known structural heart disease?
What is the pathophysiology, clinical presentation, diagnostic work‑up, and management of bradycardia (heart rate <60 beats/min)?
Can a vagus nerve stimulator (VNS) cause bradycardia?
How should I evaluate and treat a 27-year-old man with intermittent symptomatic bradycardia (heart rate 42–55 bpm) causing lightheadedness and nausea?
What are the indications and recommended device types for cardiac pacing in adult patients with symptomatic bradycardia?
Are there any drug interactions or safety concerns when taking Cogmax Fos (phosphatidylserine, choline, magnesium bisglycinate, zinc, vitamin B‑complex supplement) together with tenofovir for HIV treatment or pre‑exposure prophylaxis?
How should I manage increased anxiety in a 19-year-old female with agoraphobia and atypical anorexia who is taking escitalopram 15 mg and had her aripiprazole (Abilify) dose increased from 2 mg to 4 mg?
What water management strategies can be employed to prevent dengue transmission?
Is epigastric pain that occurs when coughing indicative of a hiatal hernia?
If I receive 3 L of intravenous 0.9 % saline over two days, will my serum osmolality increase in the setting of undiagnosed diabetes insipidus?
For a child with a confirmed distal radius buckle (torus) fracture, should a removable short‑arm splint be used for three weeks?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.